Business
Invest Hong Kong, which supports overseas and Mainland businesses to set up or expand in Hong Kong hosted a seminar in Qingdao (20th May) encouraging local enterprises to leverage on Hong Kong’s advantages in brand building, marketing and capital raising to facilitate their development into overseas markets. Co- organisers of the seminar included the Bureau of Commerce, Qingdao, and the China Council for the Promotion of International Trade, Qingdao Sub-Council. Director-General of Investment Promotion, Mr Simon Galpin; Chairman of China Council for the Promotion of International Trade, Qingdao Sub-Council, Mr Feng Wenqing; and Vice Director General, Bureau of Commerce, Qingdao, Mr Wu Heng; delivered welcome speeches at the seminar.
In his remarks, Mr Galpin said, “Hong Kong and Qingdao are coastal port cities in prime geographical locations. In addition, Hong Kong, the world’s freest economy for 17 consecutive years, has a low and simple tax regime and allows the free flow of goods, information, capital and talent. It imposes no import or export tariffs on the majority of goods and is free of exchange controls. It is, therefore, the ideal launch pad for companies from Qingdao and other parts of the Mainland to explore overseas markets.” He also pointed out that the city is home to major international exhibitions providing the best platform for Mainland producers and suppliers to develop their business by showcasing their products and testing international waters.
Opportunities Europe and Middle East
By Heather Hobbs
With expansion a prime focus for businesses worldwide, many are looking towards rapidly establishing new regions of growth, particularly in Europe and the Middle East. This section of Lab Asia will especially look at the success of both Asian and European companies with established premises or business partnerships, highlighting the opportunities that exist while realising potential for other companies to move into export markets.
Local enterprises in Qingdao encouraged to ‘Go Global’
InvestHK is the department for Foreign Direct Investment, supporting overseas businesses to set up and expand in Hong Kong, providing free advice and customised services to help businesses succeed. For more information, please visit
www.investhk.gov.hk.
Pharma and Bio events to boost Japanese markets Following the postponement of CPhI, ICSE, P-MEC and BioPh
Japan in Tokyo as a result of the recent earthquake, events organiser UBM live aims to reinvigorate the supply chain through rescheduled events being held at the Intex Osaka Exhibition Centre, 13-15 July 2011. UBM anticipates that the Osaka events will attract over 150 exhibitors and around 8,000 visitors. Japan's second largest city, Osaka is also the centre of the Kansai area, one of the main regions in Japan for pharmaceutical R&D and manufacturing, with numerous Japanese and multinational pharmaceutical companies having their head office, factories and R&D centres located there, and in surrounding cities.
Director-General of Investment Promotion, Mr Simon Galpin, encourages Qingdao businesses to "Go Global" during a seminar in Qingdao (20th May).
TO FIND OUT MORE CIRCLE NO. 427 Nanostart Asia sells shareholding in Curiox
Nanostart Asia, a subsidiary of Nanostart AG has sold its ownership stake in Curiox Biosystems Pte Ltd – held through the Nanostart Singapore Early Stage Venture Fund – to the Zicom Group. Proceeds received by Nanostart have been returned to the fund for further investment.
"We already decided at a relatively early stage to sell our share in Curiox to the Zicom Group, an investor with a strategic interest. We remain convinced of the developmental potential of Curiox," explained Andreas Kröll, Managing Director of Nanostart Asia. "We carefully compared the additional financial costs and our earnings forecast for invested capital with our overall earnings goals."
Curiox Biosystems, which has developed a process for analysing aqueous bioprobes requiring only a fraction of the usually required testing quantity, was the first shareholding financed by Nanostart AG in 2007. Acquiring company, Zicom Group, a leading equipment manufacturer and niche engineering service provider has core expertise in mechanical, hydraulics, precision, and instrumentation engineering.
The government of Singapore has, through its National Research Foundation (NRF), invested SGD 10 million (approximately EUR 5 million) in this venture fund which is dedicated to bringing promising nanotechnology-based start-ups in Singapore to successful commercialisation.
TO FIND OUT MORE CIRCLE NO. 429 ICSE China to Offer Inaugural Conference Programme
UBM Live has introduced a conference programme into ICSE China, an event dedicated to pharmaceutical contract services and outsourcing. ICSE, hosted from 21-23 June, 2011 at the SNIEC China, will run alongside CPhI China for pharmaceutical ingredients, P-MEC China for pharma machinery and equipment, BioPh China for the biopharmaceuticals market and the new LABWorld pavilion for laboratory, analytical and biotechnology instrumentation technologies. Over 2,000 exhibitors and 27,000 visitors are expected over the three days. Attendance to the events is free through pre-registration at
www.cphi-china.com
The inaugural China conference series, titled ‘Pharma R&D and Collaboration Strategies’, will address global pharmaceutical issues, with an emphasis on China’s pharma market, across key areas such as
New Drug Discovery, Biopharm, Biosimilars, CRO/CMO, API Sourcing, Generics and Export Strategies and more. It will bring together Chinese and global pharma companies to explore different views regarding the China pharmaceutical market.
Thirty eminent speakers from international pharmaceutical companies and research institutes, such as the FDA, Novartis, USP-China, Roche R&D Center, GSK China/HK, AstraZeneca Innovation Centre China, Sanofi-Aventis, REVA PHARMA, Dr. Reddy's and Shanghai Pharma, will share their knowledge and research strategies. Additionally, in-depth case studies covering R&D and business development strategies will be presented by an outstanding panel of Chinese, Indian and international speakers from industry- leading companies and associations.
TO FIND OUT MORE CIRCLE NO. 430
“Since events were initially cancelled many requests were received from exhibitors asking for an opportunity to meet and network with clients in Japan this year,” commented Annemieke Timmers, CPhI Brand Director. “We also received unanimous feedback from our Japanese customers and we recognise that it is precisely at times such as this that CPhI Japan, along with ICSE, P-MEC and BioPh Japan, could help contribute towards the stable supply of pharmaceutical products in what is the second largest pharma market after the United States.”
“We are currently putting together a schedule of conference sessions which will run alongside the events over the three-day period. These will cover a wide variety of topics relevant to each of the co-located shows that will enhance the educational experience for exhibitors and visitors alike,” Haf Cennydd, Brand Director ICSE, P-MEC and BioPh added.
Further information on CPhI, ICSE, P-MEC and BioPh Japan can be found at
www.cphijapan.com
TO FIND OUT MORE CIRCLE NO. 428
BGI becomes CSP for Genomics System in China
Agilent Technologies has appointed major genomics research centre BGI, Certified Service Provider (CSP) status for its SureSelect XT Target Enrichment System for next-generation sequencing. Shenzhen-based BGI, said to be the largest genomic organisation in the world, becomes the first CSP in China certified for this system’s protocols including human all- exon, SureSelect indexing, DNA capture, RNA capture, kinome RNA and custom kits.
"We are very pleased to be an Agilent CSP,” said Li Jingxiang, Director, Genome Sequencing Operations, BGI. “The Agilent SureSelect XT Target Enrichment System is an excellent and internationally renowned product, with which we can deliver the best exome target sequencing service to our customers.”
“We’re extremely pleased that this premier sequencing centre is making the benefits of SureSelect XT Target Enrichment available across the very wide range of genomics experiments that it performs,” said Fred P. Ernani, PhD, Agilent Genomics Marketing Director, SureSelect platform.
TO FIND OUT MORE CIRCLE NO. 431
Does your company sell or wish to sell laboratory products and services to the economies of Europe and the Middle East? Are you looking for local distributors and agents to represent you? If so, why not advertise your products in our market-leading journal International Labmate.
Contact us today for more information Email:
info@intlabmate.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
